NDC 59726-227 Aspirin Low Dose Safety Coated
Tablet Oral - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 59726 - P & L Development, Llc
- 59726-227 - Aspirin
Product Characteristics
Product Packages
NDC Code 59726-227-03
Package Description: 300 TABLET in 1 BOTTLE
NDC Code 59726-227-10
Package Description: 1000 TABLET in 1 BOTTLE, PLASTIC
NDC Code 59726-227-60
Package Description: 1 BOTTLE in 1 CARTON / 60 TABLET in 1 BOTTLE
Product Details
What is NDC 59726-227?
What are the uses for Aspirin Low Dose Safety Coated?
What are Aspirin Low Dose Safety Coated Active Ingredients?
- ASPIRIN 81 mg/1 - The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
Which are Aspirin Low Dose Safety Coated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ASPIRIN (UNII: R16CO5Y76E)
- ASPIRIN (UNII: R16CO5Y76E) (Active Moiety)
Which are Aspirin Low Dose Safety Coated Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- POLYSORBATE 80 (UNII: 6OZP39ZG8H)
- DIMETHICONE (UNII: 92RU3N3Y1O)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- SODIUM LAURYL SULFATE (UNII: 368GB5141J)
- TALC (UNII: 7SEV7J4R1U)
- TRIETHYL CITRATE (UNII: 8Z96QXD6UM)
- ANHYDROUS LACTOSE (UNII: 3SY5LH9PMK)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
- BROWN IRON OXIDE (UNII: 1N032N7MFO)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)
- FD&C YELLOW NO. 6 (UNII: H77VEI93A8)
- HYPROMELLOSES (UNII: 3NXW29V3WO)
- METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) (UNII: 74G4R6TH13)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- MINERAL OIL (UNII: T5L8T28FGP)
- POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)
- STARCH, CORN (UNII: O8232NY3SJ)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- WATER (UNII: 059QF0KO0R)
- SHELLAC (UNII: 46N107B71O)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- SODIUM BICARBONATE (UNII: 8MDF5V39QO)
- STEARIC ACID (UNII: 4ELV7Z65AP)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
What is the NDC to RxNorm Crosswalk for Aspirin Low Dose Safety Coated?
- RxCUI: 308416 - aspirin 81 MG Delayed Release Oral Tablet
- RxCUI: 308416 - ASA 81 MG Delayed Release Oral Tablet
- RxCUI: 308416 - aspirin 81 MG Enteric Coated Oral Tablet
Which are the Pharmacologic Classes for Aspirin Low Dose Safety Coated?
- Anti-Inflammatory Agents, Non-Steroidal - [CS]
- Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
- Decreased Platelet Aggregation - [PE] (Physiologic Effect)
- Decreased Prostaglandin Production - [PE] (Physiologic Effect)
- Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
- Platelet Aggregation Inhibitor - [EPC] (Established Pharmacologic Class)
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[10] What is the End Marketing Date? - This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".